What is Leerink Partnrs’ Forecast for REGENXBIO Q2 Earnings?
REGENXBIO Inc. (NASDAQ:RGNX – Free Report) – Investment analysts at Leerink Partnrs lifted their Q2 2025 earnings per share estimates for REGENXBIO in a report released on Monday, May 19th. Leerink Partnrs analyst M. Foroohar now anticipates that the biotechnology company will earn ($0.89) per share for the quarter, up from their prior estimate of […]
REGENXBIO Inc. (NASDAQ:RGNX – Free Report) – Investment analysts at Leerink Partnrs lifted their Q2 2025 earnings per share estimates for REGENXBIO in a report released on Monday, May 19th. Leerink Partnrs analyst M. Foroohar now anticipates that the biotechnology company will earn ($0.89) per share for the quarter, up from their prior estimate of […]
